VANDEPUTTE MEDICAL
0839.310.910 · rovalta.com · 26/09/2026
ACTIVE
VANDEPUTTE MEDICAL
Financial year 2025 · Closed on 31/12/2025
Net result96 k €-50,5 %over 1 year
Gross margin1,3 M €-12,4 %over 1 year
Equity404,5 k €+31,1 %over 1 year
Workforce9,9 ETP+2,1 %over 1 year
Overview
Identity
Source · BCE/KBOVANDEPUTTE MEDICAL is a Public limited company incorporated in 2011. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Antwerpen. It employs on average 9,9 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0839.310.910
- Incorporation
- 15/09/2011
- Legal form
- Public limited company
- Registered office
- Uitbreidingstraat 2
2600 Antwerpen · FlandreSee on map - Contributed capital
- 100 000,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 9,9 ETP
Joint committees (2)
- 20000
- 218
Signals
ProfitableLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
Financials
Source · NBB, 14 filingsTrend over 5 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 1,3 M € | -12.4% | 1,5 M € | +46.6% | 1 M € | +18.2% | 857,3 k € | -17.6% | 1 M € |
| EBITDA | 201,5 k € | -41.3% | 343,4 k € | +983% | -38,9 k € | -129% | 134,3 k € | -63.5% | 367,9 k € |
| Operating result | 153,2 k € | -46.8% | 288,3 k € | +419% | -90,4 k € | -293% | 46,7 k € | -84.3% | 297,7 k € |
| Net result | 96 k € | -50.5% | 194 k € | +870% | 20 k € | -87.4% | 159,1 k € | -26.7% | 217 k € |
| Balance sheet | |||||||||
| Equity | 404,5 k € | +31.1% | 308,5 k € | +169% | 114,5 k € | -61.1% | 294,5 k € | -12.2% | 335,4 k € |
| Total assets | 1,5 M € | -21.1% | 1,9 M € | +37.1% | 1,4 M € | -1.4% | 1,4 M € | -17.1% | 1,7 M € |
| Cash | 301,3 k € | +41.0% | 213,7 k € | +116% | 99,1 k € | -72.5% | 359,7 k € | -9.0% | 395,4 k € |
| Debts | 994,9 k € | -31.0% | 1,4 M € | +21.1% | 1,2 M € | +12.6% | 1,1 M € | -16.6% | 1,3 M € |
| Other | |||||||||
| Workforce | 9,9 ETP | +2.1% | 9,7 ETP | +3.2% | 9,4 ETP | +13.3% | 8,3 ETP | +1.2% | 8,2 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20252 active · 13 ended
Active mandates
Julie Vandeputte
ActiveActive
Ended mandates
Jan Van den Bergh
EndedYves Pauwels
EndedWalter Vandeputte
EndedAntonius Grimminck
EndedOther companies at this address
Uitbreidingstraat 2 2600 Antwerpen| Company | CBE no. |
|---|---|
BASIELFOOD● Bankrupt | 0695.510.586 |
| 0817.544.902 | |
Delaware Germany● Active | 0779.741.923 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 17/06/2026 | 15/07/2025 | 04/07/2024 | 25/06/2023 | 05/05/2022 | 13/04/2021 |
| General meeting | 26/05/2026 | 16/06/2025 | 28/05/2024 | 23/06/2023 | 04/05/2022 | 07/04/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 14 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 26/05/2026 | 17/06/2026 | Dutch | |
| Abridged model | 31/12/2024 | 16/06/2025 | 15/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 28/05/2024 | 04/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 23/06/2023 | 25/06/2023 | Dutch | |
| Abridged model | 31/12/2021 | 04/05/2022 | 05/05/2022 | Dutch | |
| Abridged model | 31/12/2020 | 07/04/2021 | 13/04/2021 | Dutch | |
| Abridged model | 31/12/2019 | 25/06/2020 | 30/06/2020 | Dutch | |
| Abridged model | 31/12/2018 | 28/05/2019 | 25/06/2019 | Dutch | |
| Full model | 31/12/2017 | 22/05/2018 | 24/07/2018 | Dutch | |
| Full model | 31/12/2016 | 08/05/2017 | 28/07/2017 | Dutch | |
| Full model | 31/12/2015 | 24/05/2016 | 05/08/2016 | Dutch | |
| Full model | 31/12/2014 | 26/05/2015 | 28/08/2015 | Dutch | |
| Full model | 31/12/2013 | 27/05/2014 | 10/07/2014 | Dutch | |
| Abridged model | 31/12/2012 | 28/05/2013 | 31/05/2013 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active · 13 ended
Active mandates
Julie Vandeputte
ActiveActive
Ended mandates
Jan Van den Bergh
EndedYves Pauwels
EndedWalter Vandeputte
EndedAntonius Grimminck
EndedOwnership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other22/09/2026—
- Mandates21/08/2026ONTSLAGEN, BENOEMINGEN
- Mandates09/04/2026ONTSLAGEN - BENOEMINGEN
- Other28/10/2024DIVERSEN
- Mandates12/06/2024ONTSLAGEN - BENOEMINGEN
- Mandates06/04/2023ONTSLAGEN - BENOEMINGEN
- Mandates23/12/2020STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ONTSLAGEN - BENOEMINGEN - MAATSCHAPPELIJKE ZETEL
- Mandates06/11/2020ONTSLAGEN - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202596 k €↓
- 2024Annual accounts 2024194 k €↑
- 2023Annual accounts 202320 k €↓
- 2022Annual accounts 2022159,1 k €↓
- 2021Annual accounts 2021217 k €
- 15/09/2011IncorporationPublic limited company